Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOGF


Primary Symbol: C.ACOG

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

CSE:ACOG - Post Discussion

Alpha Cognition Inc > Big day for $ACOG, my current top pick!!
View:
Post by partystocker on Oct 01, 2021 11:29am

Big day for $ACOG, my current top pick!!

They just announced they closed their public offering and raised $14.4M! $ACOG.V issued 9.6M units at $1.50 per unit. 


Warrants are gonna start trading on the TSXV under ticker $ACOG.WT next week!


$ACOG is gonna be using the $$ made from the offering for development and marketing of ALPHA-1062, the company’s lead developmental treatment candidate atm. 


PLUS they just formed a Scientific Advisory Board that's packed with pros from the neurology and psychiatry industry. The board is gonna be working to bring $ACOG closer to commercialization. 


they will also have a huge focus on developing products that can treat neurological diseases with unmet needs, like dementia and Alzheimer's, and furthering developing ALPHA-1062.


I have no doubt the new SAB will speed up the process of the company becoming the creator of the world’s first Alzheimer’s treatment. I just am so stoked to see all this progress happening for the company!! 


Td, $ACOG is up at $1.37, MC $71.03M.

 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities